Matches in Wikidata for { <http://www.wikidata.org/entity/Q90312201> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90312201 description "2020 թվականի մարտի 10-ին հրատարակված գիտական հոդված" @default.
- Q90312201 description "article scientifique publié en 2020" @default.
- Q90312201 description "artykuł naukowy opublikowany 10 marca 2020" @default.
- Q90312201 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90312201 description "scientific article published on 10 March 2020" @default.
- Q90312201 description "wetenschappelijk artikel" @default.
- Q90312201 description "наукова стаття, опублікована 10 березня 2020" @default.
- Q90312201 name "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 name "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 type Item @default.
- Q90312201 label "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 label "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 prefLabel "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 prefLabel "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 P1433 Q90312201-A1AFF671-026C-41BE-B1DB-65D7B1D0620F @default.
- Q90312201 P1476 Q90312201-14361DD3-A263-46C4-B874-ADB66F6EDD60 @default.
- Q90312201 P2093 Q90312201-826B517A-D7DF-48FA-BADA-FC9E6C561238 @default.
- Q90312201 P304 Q90312201-8FEC5E9A-524C-44E9-8A84-464C4B4B5937 @default.
- Q90312201 P31 Q90312201-B7110981-29A6-4E45-9870-900DDF818739 @default.
- Q90312201 P356 Q90312201-A2B69733-00BD-48CC-A613-FD93D02B043C @default.
- Q90312201 P478 Q90312201-6D6FF681-FE86-4ACC-B1AF-7F3A2C512418 @default.
- Q90312201 P577 Q90312201-235901E8-4AF5-4495-909B-434D0B4C2816 @default.
- Q90312201 P698 Q90312201-EBB78A1F-28CD-44EB-B80E-A1F37B24BA55 @default.
- Q90312201 P921 Q90312201-0213DCD4-C457-450E-BAAA-B695F80AF462 @default.
- Q90312201 P921 Q90312201-A5A2B8BF-BA5F-4E8F-8684-A8FB420994E0 @default.
- Q90312201 P356 J.BCP.2020.113905 @default.
- Q90312201 P698 32169417 @default.
- Q90312201 P1433 Q864229 @default.
- Q90312201 P1476 "Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)" @default.
- Q90312201 P2093 "Karl Walter Bock" @default.
- Q90312201 P304 "113905" @default.
- Q90312201 P31 Q13442814 @default.
- Q90312201 P356 "10.1016/J.BCP.2020.113905" @default.
- Q90312201 P478 "175" @default.
- Q90312201 P577 "2020-03-10T00:00:00Z" @default.
- Q90312201 P698 "32169417" @default.
- Q90312201 P921 Q1546498 @default.
- Q90312201 P921 Q6058862 @default.